Experiment: 7NT7

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.8 mM [U-100% 13C; U-100% 15N] TLR1-TIR, 20 mM PIPES, 25 mM sodium chloride, 3 mM TCEP	95% H2O/5% D2O	50 mM	6.3	AMBIENT Pa	308	Bruker AVANCE III 800
2	3D HNCACB	0.8 mM [U-100% 13C; U-100% 15N] TLR1-TIR, 20 mM PIPES, 25 mM sodium chloride, 3 mM TCEP	95% H2O/5% D2O	50 mM	6.3	AMBIENT Pa	308	Bruker AVANCE III 800
3	3D HCCH-TOCSY	0.8 mM [U-100% 13C; U-100% 15N] TLR1-TIR, 20 mM PIPES, 25 mM sodium chloride, 3 mM TCEP	95% H2O/5% D2O	50 mM	6.3	AMBIENT Pa	308	Bruker AVANCE III 800
4	3D HCCH-COSY	0.8 mM [U-100% 13C; U-100% 15N] TLR1-TIR, 20 mM PIPES, 25 mM sodium chloride, 3 mM TCEP	95% H2O/5% D2O	50 mM	6.3	AMBIENT Pa	308	Bruker AVANCE III 800
5	3D 1H-13C NOESY	0.8 mM [U-100% 13C; U-100% 15N] TLR1-TIR, 20 mM PIPES, 25 mM sodium chloride, 3 mM TCEP	95% H2O/5% D2O	50 mM	6.3	AMBIENT Pa	308	Bruker AVANCE III 800
6	3D 1H-13C NOESY aromatic	0.8 mM [U-100% 13C; U-100% 15N] TLR1-TIR, 20 mM PIPES, 25 mM sodium chloride, 3 mM TCEP	95% H2O/5% D2O	50 mM	6.3	AMBIENT Pa	308	Bruker AVANCE III 800
7	3D 1H-15N NOESY	0.8 mM [U-100% 13C; U-100% 15N] TLR1-TIR, 20 mM PIPES, 25 mM sodium chloride, 3 mM TCEP	95% H2O/5% D2O	50 mM	6.3	AMBIENT Pa	308	Bruker AVANCE III 800

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	800

NMR Refinement
Method	Details	Software
torsion angle dynamics		CYANA

NMR Ensemble Information
Conformer Selection Criteria	structures with the least restraint violations
Conformers Calculated Total Number	200
Conformers Submitted Total Number	20
Representative Model	1 (fewest violations)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure calculation	CYANA	3.98.13	Guntert, Mumenthaler and Wuthrich
2	chemical shift assignment	CARA	1.9.1	Keller and Wuthrich
3	processing	qMDD	2.7	Orekhov, Mayzel
4	processing	TopSpin		Bruker Biospin
5	peak picking	CARA	1.9.1	Keller and Wuthrich

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.